The US FDA has approved a label extension for UCB’s Cimzia (certolizumab pegol ... chronic inflammatory disease primarily affecting the skin. Signs and symptoms vary but may include red ...

NICE has recommended in draft guidance that UCB’s Cimzia can receive regular NHS funding ... red scaly plaques on the skin. A digital health passport is an app, or online certification, that ...